We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Agilent Obtains Multicolor, CGH Microarray Licenses from Abbott

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Agilent Obtains Multicolor, CGH Microarray Licenses from Abbott "

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Agilent Technologies Inc. has announced it has obtained worldwide, non-exclusive patent licenses from Abbott Molecular Inc. for the manufacture, marketing and sale of oligonucleotide microarrays using a two-or-more color technology for gene expression and comparative genomic hybridization (CGH) applications.

This broad license covers microarray applications, including research, commercial laboratories and in vitro diagnostics.

Expressly built into the grant of rights are related products, instruments, components and services.

"This intellectual property complements other recent Agilent investments in microarray fabrication technology and software," said Nick Roelofs, vice president and general manager of Agilent’s Life Sciences Solutions Unit. "Our intent is to help researchers unlock the full potential of genomics."